Invesco Ltd. Cytom X Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 37,464 shares of CTMX stock, worth $39,711. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,464

Previous 23,094 62.22%

Holding current value

$39,711

Previous $28,000 57.14%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.12 - $1.51 $16,094 - $21,698	14,370 Added 62.22%	37,464 $44,000
Q2 2024 Aug 13, 2024	BUY	$1.21 - $5.13 $27,943 - $118,472	23,094 New	23,094 $28,000
Q3 2023 Nov 13, 2023	BUY	$1.26 - $1.87 $3,292 - $4,886	2,613 Added 13.43%	22,071 $28,000
Q2 2023 Aug 11, 2023	BUY	$1.41 - $1.92 $9,014 - $12,274	6,393 Added 48.93%	19,458 $33,000
Q1 2023 May 12, 2023	SELL	$1.48 - $2.88 $586 - $1,140	-396 Reduced 2.94%	13,065 $19,000
Q4 2022 Feb 13, 2023	BUY	$1.19 - $1.91 $16,018 - $25,710	13,461 New	13,461 $21,000
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $36,150 - $68,284	-23,628 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.67 - $4.68 $1,946 - $3,411	729 Added 3.18%	23,628 $63,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $28,158 - $53,769	-7,276 Reduced 24.11%	22,899 $99,000
Q3 2021 Nov 15, 2021	BUY	$4.32 - $6.43 $20,952 - $31,185	4,850 Added 19.15%	30,175 $154,000
Q2 2021 Aug 17, 2021	BUY	$6.33 - $9.91 $80,118 - $125,430	12,657 Added 99.91%	25,325 $161,000
Q1 2021 May 17, 2021	SELL	$6.6 - $9.0 $94,815 - $129,294	-14,366 Reduced 53.14%	12,668 $98,000
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $35,921 - $43,860	5,552 Added 25.84%	27,034 $177,000
Q3 2020 Nov 16, 2020	SELL	$6.55 - $8.83 $3,235 - $4,362	-494 Reduced 2.25%	21,482 $143,000
Q2 2020 Aug 14, 2020	SELL	$7.4 - $14.64 $17,145 - $33,920	-2,317 Reduced 9.54%	21,976 $183,000
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $87,697 - $208,919	24,293 New	24,293 $186,000
Q3 2019 Nov 14, 2019	SELL	$7.38 - $12.25 $392,918 - $652,202	-53,241 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $62,766 - $76,595	-6,713 Reduced 11.2%	53,241 $597,000
Q1 2019 May 15, 2019	SELL	$9.5 - $19.16 $118,940 - $239,883	-12,520 Reduced 17.28%	59,954 $645,000
Q4 2018 Feb 14, 2019	BUY	$12.69 - $18.61 $919,695 - $1.35 Million	72,474 New	72,474 $1.09 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account